Pharma and BioTech Daily

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of significant advancements and strategic shifts shaping the industry landscape. We begin with the integration of artificial intelligence into drug discovery. GSK's recent collaboration with Chai Discovery exempli...

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into some of the most significant advancements and challenges shaping these dynamic sectors. In a notable regulatory update, the U.S. Food and Drug Administration has expanded the label for Novartis' Rhapsido to include symptomatic...

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of impactful advancements and strategic shifts shaping the industry landscape. Cerevance has made headlines with its drug Solengepras achieving a major milestone in a Phase 3 trial for Parkinson's disease. The dru...

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. The pharmaceutical industry is no stranger to dynamic growth, as evidenced by Shionogi's recent acquisition of Intrabio for a staggering $2 billion. This move is more than just a financial transaction; it represents a strategic pivot towards addre...

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of groundbreaking advancements and strategic shifts that are defining the industry's path forward. Bayer has made headlines with its strategic $2.2 billion investment in a new Ohio manufacturing site. This move hi...